SCHEDULE: Farallon Capital Discloses InflaRx Stake
Beneficial Ownership Filing
Farallon Capital Management, L.L.C. and associated entities have reported beneficial ownership of 3,325,000 ordinary shares, representing 2.3% of the class, in InflaRx N.V.
Summary
- Farallon Capital Management, L.L.C. and related entities have filed a Schedule 13G, indicating their beneficial ownership of InflaRx N.V. ordinary shares.
- The total number of shares beneficially owned is 3,325,000, which constitutes 2.3% of the outstanding class of securities.
- This filing is an amendment, with the event date requiring the filing being June 30, 2026.
- The reporting persons are identified as Farallon Capital Management, L.L.C. and various associated investment partnerships and individuals.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports on beneficial ownership changes and does not contain operational or financial performance updates.
Future Outlook
This filing does not contain any forward-looking statements or guidance.
Industry Context
StockSavvy.ai notes that Schedule 13G filings are routine disclosures for significant beneficial ownership changes and do not typically reflect company performance or strategic shifts.
Key Dates
| Date | Description |
|---|---|
| 06/30/2026 | Date of event which requires filing of this statement |
| 08/14/2026 | Date of signatures on the filing |
Keywords
InflaRx N.V., Schedule 13G, Beneficial Ownership, Farallon Capital Management, Ordinary Shares, Investment Partnerships
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.